Other diseases
Coronary heart disease
冠心病
A condition in which the coronary arteries cannot supply as much blood as the heart muscle needs. It is a form of myocardial ischaemia.
Definition adapted from MeSH (US National Library of Medicine)
- hospitals in mainland China
- 231
- cities
- 64
with a paper from 2016–2025 or a registered study
where those hospitals are
Mainland China accounts for 22% of the world's English-language research papers on coronary heart disease, 2021–2025 (13% in 2016–2020), and 12% of the world's registered trials on it have a site in China.
Research activity in public records, not a rating of care and not medical advice. How the numbers are made
231 hospitals in 64 cities
Order: papers led on coronary heart disease, 2021–2025, then A–Z. Research activity, not a rating of care.
A hospital is listed when it led at least 6 papers or 1 trial on coronary heart disease, or was a site in 4 or more trials. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first. Hospitals not listed may also treat it. Definitions
Cities with the most listed hospitals
Each opens coronary heart disease in that city. 54 more cities are in the menu below.
- 243 papers led
- 196 papers led
- 109 papers led
- 101 papers led
- 87 papers led
- 76 papers led
- 65 papers led
- 59 papers led
- 52 papers led
- 48 papers led
- 46 papers led
- 42 papers led
- 41 papers led
- 36 papers led
- 36 papers led
- 36 papers ledNo open trial led
- 36 papers led
- 35 papers led
- 34 papers led
- 34 papers ledNo open trial led
- 34 papers ledNo open trial led
- 30 papers led
- 30 papers ledNo open trial led
- 29 papers led
- 29 papers ledNo open trial led
- 28 papers ledNo open trial led
- 27 papers ledNo open trial led
- 26 papers led
- 26 papers ledNo open trial led
- 26 papers led
- 25 papers led
- 25 papers ledNo open trial led
- 25 papers ledNo open trial led
- 25 papers ledNo open trial led
- 24 papers ledNo open trial led
- 24 papers ledNo open trial led
- 24 papers led
- 23 papers ledNo open trial led
- 23 papers led
- 23 papers ledNo open trial led
- 23 papers led
- 22 papers led
- 22 papers ledNo open trial led
- 21 papers ledNo open trial led
- 21 papers led
- 21 papers ledNo open trial led
- 21 papers ledNo open trial led
- 21 papers ledNo open trial led
- 20 papers ledNo open trial led
- 20 papers led
- 20 papers ledNo open trial led
- 20 papers led
- 20 papers ledNo open trial led
- 18 papers led
- 18 papers ledNo open trial led
- 18 papers ledNo open trial led
- 18 papers ledNo open trial led
- 18 papers ledNo open trial led
- 17 papers led
- 17 papers ledNo open trial led
- 17 papers ledNo open trial led
- 17 papers led
- 17 papers ledNo open trial led
- 16 papers ledNo open trial led
- 16 papers ledNo open trial led
- 16 papers led
- 16 papers ledNo open trial led
- 15 papers ledNo open trial led
- 15 papers ledNo open trial led
- 15 papers ledNo open trial led
- 15 papers ledNo open trial led
- 15 papers ledNo open trial led
- 15 papers ledNo open trial led
- 15 papers ledNo open trial led
- 15 papers led
- 14 papers ledNo open trial led
- 14 papers ledNo open trial led
- 13 papers ledNo open trial led
- 13 papers ledNo open trial led
- 13 papers ledNo open trial led
- 13 papers ledNo open trial led
- 12 papers ledNo open trial led
- 12 papers ledNo open trial led
- 12 papers ledNo open trial led
- 12 papers led
- 12 papers led
- 12 papers ledNo open trial led
- 12 papers ledNo open trial led
- 12 papers ledNo open trial led
- 11 papers ledNo open trial led
- 11 papers ledNo open trial led
- 11 papers ledNo open trial led
- 11 papers ledNo open trial led
- 11 papers ledNo open trial led
- 11 papers ledNo open trial led
- 11 papers ledNo open trial led
- 11 papers ledNo open trial led
- 10 papers ledNo open trial led
- 10 papers ledNo open trial led
- 10 papers ledNo open trial led
- 10 papers ledNo open trial led
- 9 papers ledNo open trial led
- 9 papers ledNo open trial led
- 9 papers led
- 9 papers ledNo open trial led
- 9 papers ledNo open trial led
- 9 papers ledNo open trial led
- 9 papers ledNo open trial led
- 9 papers ledNo open trial led
- 9 papers ledNo open trial led
- 9 papers ledNo open trial led
- 9 papers ledNo open trial led
- 8 papers ledNo open trial led
- 8 papers ledNo open trial led
- 8 papers ledNo open trial led
- 8 papers ledNo open trial led
- 8 papers ledNo open trial led
- 8 papers ledNo open trial led
- 8 papers ledNo open trial led
- 8 papers ledNo open trial led
- 8 papers ledNo open trial led
- 8 papers ledNo open trial led
- 8 papers ledNo open trial led
- 8 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 7 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 5 papers ledNo open trial led
- 5 papers ledNo open trial led
- 5 papers ledNo open trial led
- 5 papers ledNo open trial led
- 5 papers ledNo open trial led
- 5 papers ledNo open trial led
- 5 papers ledNo open trial led
- 5 papers led
- 5 papers ledNo open trial led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
- 3 papers ledNo open trial led
- 3 papers ledNo open trial led
- 3 papers ledNo open trial led
- 3 papers ledNo open trial led
- 3 papers ledNo open trial led
- 3 papers ledNo open trial led
- 3 papers ledNo open trial led
- 3 papers ledNo open trial led
- 3 papers ledNo open trial led
- 3 papers ledNo open trial led
- 2 papers ledNo open trial led
- 2 papers ledNo open trial led
- 2 papers ledNo open trial led
- 2 papers led
- 2 papers ledNo open trial led
- 2 papers ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers led
No listed hospital matches these filters.
By university or health system 58
Hospitals carrying a university’s name, added together, plus papers that name only the university. Same order as above.
- 335 papers led6 hospitals
- 320 papers led6 hospitals
- 156 papers led6 hospitals
- 150 papers led6 hospitals
- 146 papers led6 hospitals
- 115 papers led5 hospitals
- 107 papers led6 hospitals
- 94 papers led6 hospitals
- 89 papers led6 hospitals
- 86 papers led6 hospitals
- 85 papers led6 hospitals
- 78 papers led6 hospitals
- 76 papers led1 hospital
- 75 papers led6 hospitals
- 73 papers led6 hospitals
- 67 papers led6 hospitals
- 64 papers led6 hospitals
- 58 papers led6 hospitals
- 55 papers led6 hospitals
- 54 papers led5 hospitals
- 53 papers led4 hospitals
- 51 papers led5 hospitals
- 51 papers led5 hospitals
- 51 papers led6 hospitals
- 47 papers led5 hospitals
- 44 papers led3 hospitals
- 42 papers led6 hospitals
- 39 papers led6 hospitals
- 39 papers led5 hospitals
- 38 papers led6 hospitals
- 37 papers led6 hospitals
- 37 papers led2 hospitals
- 37 papers led6 hospitals
- 33 papers led2 hospitals
- 32 papers led6 hospitals
- 28 papers led4 hospitals
- 28 papers led1 hospital
- 25 papers led6 hospitals
- 24 papers led3 hospitals
- 23 papers led5 hospitals
- 22 papers led1 hospital
- 21 papers led2 hospitals
- 20 papers led6 hospitals
- 20 papers led1 hospital
- 19 papers led6 hospitals
- 19 papers led1 hospital
- 15 papers led1 hospital
- 13 papers led4 hospitals
- 11 papers led4 hospitals
- 11 papers led2 hospitals
- 11 papers led5 hospitals
- 10 papers led2 hospitals
- 9 papers led1 hospital
- 9 papers led1 hospital
- 9 papers led1 hospital
- 9 papers led2 hospitals
- 9 papers led3 hospitals
- 4 papers led1 hospital
open trials on coronary heart disease in China
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with at least one listed hospital as lead sponsor or site. 126 of them are led by a listed hospital. Check the registry for the current status. Whether someone can take part is decided by the study team.
Trials registered only in China’s own registry (ChiCTR) are not included. Questions to check before asking about a trial
What the phases mean (US National Cancer Institute)
- RecruitingHelium-free Magnetocardiography Guided Therapy for Stable Coronary Artery Disease - A Randomized Controlled Trial
- Phase
- N/A
- Started
- 2026-03
- Posted
- Registry
- NCT07341932
Age 18 years to 80 years (registered criteria)
Led by Beijing Anzhen HospitalBeijing
- RecruitingColchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial
- Phase
- Phase 4
- Started
- 2026-01
- Posted
- Registry
- NCT07349875
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- RecruitingPrecision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis
- Phase
- Phase 4
- Started
- 2026-06
- Posted
- Registry
- NCT07362966
Age 40 years to 85 years (registered criteria)
Led by Shenyang Northern HospitalShenyang
- RecruitingWeight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial
- Phase
- N/A
- Started
- 2026-04
- Posted
- Registry
- NCT07514611
Age 18 years to 65 years (registered criteria)
Led by Guangdong Provincial People's HospitalGuangzhou
- RecruitingA Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Phase
- Phase 2
- Started
- 2026-07
- Posted
- Registry
- NCT07521007
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Lanzhou, Shanghai, Suzhou, Tianjin, Wuhan, Xi'an
- RecruitingSingle vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)
- Phase
- N/A
- Started
- 2026-05
- Posted
- Registry
- NCT07587099
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 8 listed hospitals as study sitesBeijing, Haikou, Harbin, Jinan, Liaocheng, Nanchang, Qingdao, Urumqi
- RecruitingImpact of Hyperemic State on Angio-IMR Performance
- Phase
- Not given
- Started
- 2026-05
- Posted
- Registry
- NCT07613996
Age 18 years to Not stated (registered criteria)
Led by Zhongshan Hospital, Fudan University; 1 listed hospital as study siteGuangzhou, Shanghai
- RecruitingSGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
- Phase
- Phase 4
- Started
- 2026-01
- Posted
- Registry
- NCT07614230
Age 18 years to 78 years (registered criteria)
Led by Chinese PLA General HospitalBeijing
- RecruitingMultimodal mAgnetic Resonance imaGIng in Cardiovascular Disease
- Phase
- Not given
- Started
- 2026-01
- Posted
- Registry
- NCT07617844
Age 18 years to Not stated (registered criteria)
Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou
- RecruitingQFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial
- Phase
- N/A
- Started
- 2026-06
- Posted
- Registry
- NCT07635407
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingEffect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
- Phase
- Phase 4
- Started
- 2026-09
- Posted
- Registry
- NCT07657676
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingConstruction of a Prospective Cohort Database for the Perioperative Period of Cardiac Surgery
- Phase
- Not given
- Started
- 2026-06
- Posted
- Registry
- NCT07662317
Age not stated (registered criteria)
Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou
- RecruitingClinical Study of Coronary Extension Catheter
- Phase
- N/A
- Started
- 2026-06
- Posted
- Registry
- NCT07742345
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingProgression, Management, and Clinical Outcomes of Coronary Artery Aneurysms
- Phase
- Not given
- Started
- 2026-07
- Posted
- Registry
- NCT07764081
Age 18 years to 80 years (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- RecruitingImpact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease
- Phase
- Not given
- Started
- 2026-09
- Posted
- Registry
- NCT07764094
Age 18 years to 80 years (registered criteria)
Led by Jiangsu Province Hospital; 2 listed hospitals as study sitesNanjing, Xuzhou
- RecruitingA Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation
- Phase
- Not given
- Started
- 2026-08
- Posted
- Registry
- NCT07766434
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingCCTA-Based vs CAG-Based CABG: A Multicenter Pragmatic Non-Inferiority Trial
- Phase
- N/A
- Started
- 2026-08
- Posted
- Registry
- NCT07769008
Age 18 years to Not stated (registered criteria)
Led by Ruijin HospitalShanghai
- RecruitingCold-Region Exposure and Cardiac Remodeling After PCI
- Phase
- Not given
- Started
- 2026-06
- Posted
- Registry
- NCT07773870
Age 18 years to 80 years (registered criteria)
Led by Chinese PLA General HospitalBeijing
- RecruitingPost-Marketing Clinical Study of High-Pressure Cutting Balloon
- Phase
- N/A
- Started
- 2026-09
- Posted
- Registry
- NCT07835178
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteXi'an
- RecruitingAspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCI
- Phase
- N/A
- Started
- 2026-03
- Posted
- Registry
- NCT07846462
Age 18 years to 85 years (registered criteria)
Led by First Hospital of Jilin UniversityChangchun
- RecruitingImpact of Stepwise Pressure-Increasing NC Balloon Post-Dilation on Stent Expansion
- Phase
- N/A
- Started
- 2026-01
- Posted
- Registry
- NCT07853261
Age 18 years to Not stated (registered criteria)
Led by First Hospital of Jilin UniversityChangchun
- RecruitingCardiopulmonary Exercise Active Health Cohort Study
- Phase
- Not given
- Started
- 2026-05
- Posted
- Registry
- NCT07935187
Age 18 years to 80 years (registered criteria)
Led by Peking University Third HospitalBeijing
- Recruiting24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
- Phase
- N/A
- Started
- 2025-06
- Posted
- Registry
- NCT06014060
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingIndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome
- Phase
- Phase 4
- Started
- 2025-05
- Posted
- Registry
- NCT06451198
Age 65 years to Not stated (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- RecruitingA Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR
- Phase
- Not given
- Started
- 2025-12
- Posted
- Registry
- NCT06712862
Age Not stated to 80 years (registered criteria)
Led by Shanghai East Hospital, Tongji UniversityShanghai
- RecruitingCRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD
- Phase
- N/A
- Started
- 2025-08
- Posted
- Registry
- NCT06820970
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteZhengzhou
- RecruitingClinical Implications of Three-vessel Ultrasonic Flow Ratio Measurement in Patients With Coronary Artery Disease
- Phase
- Not given
- Started
- 2025-06
- Posted
- Registry
- NCT06822894
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingSerial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease
- Phase
- N/A
- Started
- 2025-02
- Posted
- Registry
- NCT06843005
Age 18 years to 80 years (registered criteria)
Led by Jinling HospitalNanjing
- RecruitingClinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study
- Phase
- Not given
- Started
- 2025-04
- Posted
- Registry
- NCT06845410
Age 18 years to Not stated (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingFurther Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
- Phase
- N/A
- Started
- 2025-04
- Posted
- Registry
- NCT06863545
Age 18 years to Not stated (registered criteria)
Led by Second Affiliated Hospital, Zhejiang University; 2 listed hospitals as study sitesHangzhou
- RecruitingMetformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease
- Phase
- Phase 4
- Started
- 2025-03
- Posted
- Registry
- NCT06932874
Age 30 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingREsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease
- Phase
- Not given
- Started
- 2025-07
- Posted
- Registry
- NCT06936111
Age 18 years to 75 years (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- RecruitingCombined Coronary CT Angiography and CT Perfusion in Coronary Artery Disease (CoroFusion)
- Phase
- Not given
- Started
- 2025-01
- Posted
- Registry
- NCT06949150
Age 18 years to Not stated (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- RecruitingAGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- Phase
- N/A
- Started
- 2025-08
- Posted
- Registry
- NCT06959524
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 5 listed hospitals as study sitesBeijing, Guangzhou, Wuhan, Xi'an
- RecruitingBioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions
- Phase
- N/A
- Started
- 2025-12
- Posted
- Registry
- NCT07022587
Age 18 years to 75 years (registered criteria)
Led by Xijing HospitalXi'an
- RecruitingEffectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease
- Phase
- N/A
- Started
- 2025-08
- Posted
- Registry
- NCT07031531
Age 18 years to 45 years (registered criteria)
Lead sponsor is not a listed hospital; 11 listed hospitals as study sitesBeijing, Hangzhou, Hefei, Luoyang, Luzhou, Nanjing, Shijiazhuang, Xi'an, Yangzhou, Zhengzhou
- RecruitingA Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis
- Phase
- Not given
- Started
- 2025-06
- Posted
- Registry
- NCT07034157
Age 18 years to Not stated (registered criteria)
Led by Beijing Anzhen HospitalBeijing
- RecruitingTTE Improves Clinical Management of Stable Chest Pain
- Phase
- Not given
- Started
- 2025-01
- Posted
- Registry
- NCT07063147
Age 18 years to Not stated (registered criteria)
Led by Tianjin Chest HospitalTianjin
- RecruitingSuper High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions
- Phase
- N/A
- Started
- 2025-09
- Posted
- Registry
- NCT07093788
Age 18 years to 80 years (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- RecruitingEfficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
- Phase
- Phase 4
- Started
- 2025-11
- Posted
- Registry
- NCT07110415
Age 40 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 41 listed hospitals as study sitesBeijing, Changchun, Chengdu, Chongqing, Dalian, Daqing, Guangzhou, Guiyang, Hangzhou, Harbin, Huzhou, Jinan, Lanzhou, Nanjing, Nanning, Ningbo, Qingdao, Shanghai, Shantou, Shenyang, Shenzhen, Shijiazhuang, Tianjin, Xi'an, Yantai, Yinchuan, Zhangjiakou, Zhuhai
- RecruitingµQFR for Branch Stenosis After Single Stent in Bifurcation Lesions
- Phase
- Not given
- Started
- 2025-08
- Posted
- Registry
- NCT07116083
Age 18 years to Not stated (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- RecruitingStudy of Sivelestat Sodium in OPCABG
- Phase
- Phase 2
- Started
- 2025-08
- Posted
- Registry
- NCT07118930
Age 18 years to 75 years (registered criteria)
Led by Affiliated Hospital of Nantong UniversityNantong
- RecruitingpCAD-POAF 3 Year Follow-up
- Phase
- Not given
- Started
- 2025-08
- Posted
- Registry
- NCT07146061
Age 18 years to 85 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingCommunity Exercise Treating Effect on Cardiopulmonary Disease Patients
- Phase
- N/A
- Started
- 2025-01
- Posted
- Registry
- NCT07154355
Age 18 years to 85 years (registered criteria)
Led by Guangdong Provincial People's HospitalGuangzhou
- RecruitingHigh-Resolution CT for Heart
- Phase
- Not given
- Started
- 2025-09
- Posted
- Registry
- NCT07169201
Age 18 years to Not stated (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- RecruitingDeep Learning CAD Screening on Chest CT
- Phase
- Not given
- Started
- 2025-09
- Posted
- Registry
- NCT07181512
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesHangzhou, Ningbo
- RecruitingIntelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients
- Phase
- N/A
- Started
- 2025-12
- Posted
- Registry
- NCT07259278
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingAI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population
- Phase
- Not given
- Started
- 2025-12
- Posted
- Registry
- NCT07277686
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingAI-Driven Dynamic Prediction of Non-Target Lesion Progression After PCI: A Chinese Multicenter Cohort Study
- Phase
- Not given
- Started
- 2025-09
- Posted
- Registry
- NCT07312318
Age 18 years to Not stated (registered criteria)
Led by China-Japan Friendship HospitalBeijing
- RecruitingRisk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis
- Phase
- Not given
- Started
- 2025-01
- Posted
- Registry
- NCT07316452
Age 18 years to 45 years (registered criteria)
Led by Fu Wai HospitalBeijing
- RecruitingA Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
- Phase
- Phase 2
- Started
- 2025-03
- Posted
- Registry
- NCT07318155
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingComparing the Components of Composite Endpoints for Healthcare Providers and Patients
- Phase
- Not given
- Started
- 2025-08
- Posted
- Registry
- NCT07378137
Age 18 years to Not stated (registered criteria)
Led by Xijing HospitalXi'an
- RecruitingStudy on the Preferences for PCI Implantation Devices Among Doctors and Patients
- Phase
- Not given
- Started
- 2025-08
- Posted
- Registry
- NCT07378163
Age 18 years to Not stated (registered criteria)
Led by Xijing HospitalXi'an
- RecruitingComparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)
- Phase
- Phase 3
- Started
- 2025-11
- Posted
- Registry
- NCT07439133
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 4 listed hospitals as study sitesBeijing, Tianjin
- RecruitingClinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions
- Phase
- N/A
- Started
- 2025-04
- Posted
- Registry
- NCT07463664
Age 18 years to 80 years (registered criteria)
Led by First Affiliated Hospital of Zhengzhou University; 4 listed hospitals as study sitesBeijing, Luoyang, Xinxiang, Zhengzhou
- RecruitingMulti-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD
- Phase
- Not given
- Started
- 2025-08
- Posted
- Registry
- NCT07523880
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing, Zhengzhou
- RecruitingCAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
- Phase
- Phase 4
- Started
- 2025-11
- Posted
- Registry
- NCT07612774
Age 40 years to 75 years (registered criteria)
Led by West China Hospital; 1 listed hospital as study siteChengdu, Xi'an
- RecruitingModifiable Risk Factors for Cognitive Dysfunction in Patients With Coronary Heart Disease
- Phase
- Not given
- Started
- 2025-06
- Posted
- Registry
- NCT07657624
Age 18 years to Not stated (registered criteria)
Led by Beijing Anzhen HospitalBeijing
- RecruitingPCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study
- Phase
- Not given
- Started
- 2025-01
- Posted
- Registry
- NCT07822737
Age 18 years to Not stated (registered criteria)
Led by Beijing Chao-Yang HospitalBeijing
- RecruitingProspective Study Protocol for Multiparametric PCCT Assessment of Early Ventricular Outcomes After CABG
- Phase
- Not given
- Started
- 2025-10
- Posted
- Registry
- NCT07883499
Age 18 years to 100 years (registered criteria)
Led by Chinese PLA General HospitalBeijing
- RecruitingCoronary CT-Derived FFR-Guided Strategy Versus Medical Therapy
- Phase
- N/A
- Started
- 2024-10
- Posted
- Registry
- NCT05824520
Age 18 years to Not stated (registered criteria)
Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou
- RecruitingDiabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
- Phase
- N/A
- Started
- 2024-06
- Posted
- Registry
- NCT05831085
Age 20 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing, Hangzhou
- RecruitingOne-Month DAPT in CABG Patients
- Phase
- Phase 3
- Started
- 2024-08
- Posted
- Registry
- NCT05997693
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Changchun, Shanghai
- RecruitingClinical Outcomes of Patients With Coronary Artery Disease
- Phase
- Not given
- Started
- 2024-02
- Posted
- Registry
- NCT06216847
Age 18 years to Not stated (registered criteria)
Led by Shenyang Northern HospitalShenyang
- RecruitingCarotid Atherosclerosis in Predicting Coronary Artery Disease
- Phase
- Not given
- Started
- 2024-02
- Posted
- Registry
- NCT06253962
Age 14 years to 90 years (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- RecruitingAutomated Echocardiographic Detection of Coronary Artery Disease Using Artificial Intelligence Methods
- Phase
- Not given
- Started
- 2024-03
- Posted
- Registry
- NCT06314295
Age 18 years to 90 years (registered criteria)
Led by Beijing HospitalBeijing
- RecruitingEffects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques
- Phase
- Phase 4
- Started
- 2024-03
- Posted
- Registry
- NCT06338293
Age 18 years to 80 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingCardiovascular-Renal Adverse Prognosis Assessment System for Coronary Heart Disease With Chronic Kidney Disease Based on Metabolomics
- Phase
- Not given
- Started
- 2024-04
- Posted
- Registry
- NCT06383208
Age 18 years to 80 years (registered criteria)
Led by China-Japan Friendship HospitalBeijing
- RecruitingTreatment of Primary Coronary Artery Vascular Lesions With Biolimus Coated Coronary Balloon Dilation Catheter
- Phase
- Not given
- Started
- 2024-05
- Posted
- Registry
- NCT06385067
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteNanning
- RecruitingEffect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease
- Phase
- Phase 4
- Started
- 2024-06
- Posted
- Registry
- NCT06425120
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing, Nantong
- RecruitingSurvival and cArdiovascular eVents in Patients With Acute Myocardial Infarction
- Phase
- Not given
- Started
- 2024-03
- Posted
- Registry
- NCT06489080
Age 18 years to Not stated (registered criteria)
Led by Peking University First HospitalBeijing
- RecruitingSingle-cell Multi-omics Analyses of OCT-diagnosed Plaque Subtypes in Coronary Artery Disease (MOOP-CAD)
- Phase
- Not given
- Started
- 2024-07
- Posted
- Registry
- NCT06489119
Age 18 years to 85 years (registered criteria)
Led by Second Affiliated Hospital of Harbin Medical University; 1 listed hospital as study siteChangchun, Harbin
- RecruitingEffect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
- Phase
- Phase 4
- Started
- 2024-07
- Posted
- Registry
- NCT06520904
Age 18 years to 65 years (registered criteria)
Led by First Affiliated Hospital of Xinjiang Medical UniversityUrumqi
- RecruitingIntravascular Ultrasound-Guided PCI in Patients With Chronic Kidney Disease
- Phase
- N/A
- Started
- 2024-07
- Posted
- Registry
- NCT06567938
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Xi'an Jiaotong UniversityXi'an
- RecruitingSafety and Efficacy of Meplazumab in Patients With Coronary Artery Disease
- Phase
- Phase 2
- Started
- 2024-10
- Posted
- Registry
- NCT06572267
Age 18 years to Not stated (registered criteria)
Led by Xijing HospitalXi'an
- RecruitingA Prospective Multicenter Clinical Study: IntracOronary neaR-Infrared Spectroscopy and OptIcal Coherence Tomography for Evaluating Coronary vulNerable Plaque in Patients With diabeTes
- Phase
- Not given
- Started
- 2024-10
- Posted
- Registry
- NCT06649305
Age 18 years to Not stated (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- RecruitingA New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart Disease
- Phase
- N/A
- Started
- 2024-01
- Posted
- Registry
- NCT06681506
Age 18 years to 85 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai
- RecruitingRisk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - III
- Phase
- Not given
- Started
- 2024-07
- Posted
- Registry
- NCT06793774
Age 18 years to Not stated (registered criteria)
Led by Ruijin HospitalShanghai
- RecruitingRisk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - IV
- Phase
- Not given
- Started
- 2024-07
- Posted
- Registry
- NCT06793787
Age 18 years to Not stated (registered criteria)
Led by Ruijin HospitalShanghai
- RecruitingSeniors Integrated Longitudinal cardioVascular Evaluation of Coronary Heart Disease: a Multicenter, Prospective Registry in China (SILVER-China)
- Phase
- Not given
- Started
- 2024-11
- Posted
- Registry
- NCT06880575
Age 75 years to Not stated (registered criteria)
Led by Beijing HospitalBeijing
- RecruitingMechanisms of Brain-Heart Injury of Post-Intracranial Hemorrhage
- Phase
- Not given
- Started
- 2024-08
- Posted
- Registry
- NCT06906432
Age 18 years to 80 years (registered criteria)
Led by Beijing Tiantan HospitalBeijing
- RecruitingSTICH3C Cardiac Magnetic Resonance Observational Study
- Phase
- Not given
- Started
- 2024-03
- Posted
- Registry
- NCT07133984
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai
- RecruitingVillage-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study
- Phase
- Not given
- Started
- 2024-03
- Posted
- Registry
- NCT07149688
Age 60 years to Not stated (registered criteria)
Led by Beijing Anzhen HospitalBeijing
- RecruitingAssessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
- Phase
- Not given
- Started
- 2024-10
- Posted
- Registry
- NCT07180368
Age 65 years to Not stated (registered criteria)
Led by Xijing HospitalXi'an
- RecruitingHydration Guided by Remote Dielectric Sensing (ReDS) System for Preventing Acute Kidney Injury in Elderly Patients With Renal Insufficiency for Coronary Angiography and Intervention
- Phase
- N/A
- Started
- 2024-09
- Posted
- Registry
- NCT07394959
Age 60 years to Not stated (registered criteria)
Led by Chinese PLA General HospitalBeijing
- RecruitingAssessment of CT-FFR in Patients With CCS: A Prospective Multicenter Cohort Study
- Phase
- Not given
- Started
- 2024-09
- Posted
- Registry
- NCT07659119
Age 18 years to Not stated (registered criteria)
Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou
- RecruitingEffect of Mobile-Based Home Cardiac Rehabilitation on Coronary Plaque
- Phase
- N/A
- Started
- 2024-12
- Posted
- Registry
- NCT07660419
Age 18 years to 70 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingIdentification for High Risk of Coronary Heart Disease Based on Quantitative Analysis of Fundus Vessels and Metabolic Molecules
- Phase
- Not given
- Started
- 2024-05
- Posted
- Registry
- NCT07773064
Age 18 years to 100 years (registered criteria)
Led by Beijing Hospital; 1 listed hospital as study siteBeijing
- RecruitingValidating a Medical AI Fine-Tuning Platform for Major Diseases
- Phase
- Not given
- Started
- 2024-11
- Posted
- Registry
- NCT07795645
Age 18 years to Not stated (registered criteria)
Led by Beijing Friendship HospitalBeijing
- RecruitingComparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- Phase
- N/A
- Started
- 2023-04
- Posted
- Registry
- NCT04124120
Age 18 years to Not stated; women only (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Changchun, Shanghai
- RecruitingThe Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- Phase
- N/A
- Started
- 2023-06
- Posted
- Registry
- NCT05427370
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai
- RecruitingNOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
- Phase
- Phase 4
- Started
- 2023-11
- Posted
- Registry
- NCT05638867
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingThe FAVOR V AMI Trial
- Phase
- N/A
- Started
- 2023-01
- Posted
- Registry
- NCT05669222
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingIVUS-guided DES Implantation in Coronary Calcification
- Phase
- N/A
- Started
- 2023-04
- Posted
- Registry
- NCT05800002
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- RecruitingEfficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
- Phase
- Not given
- Started
- 2023-05
- Posted
- Registry
- NCT05860400
Age 18 years to Not stated (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingRoutine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients
- Phase
- N/A
- Started
- 2023-10
- Posted
- Registry
- NCT05923489
Age 18 years to Not stated (registered criteria)
Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou
- RecruitingDisease Characteristics of IR-CAD: a Case-control Study
- Phase
- Not given
- Started
- 2023-11
- Posted
- Registry
- NCT06007248
Age 45 years to 64 years (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingEffect of Individualized Exercise in Elderly Patients With Coronary Heart Disease
- Phase
- N/A
- Started
- 2023-10
- Posted
- Registry
- NCT06588231
Age 60 years to 75 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingProspective Registry of the Current Status of Care for Patients With Coronary Artery Disease
- Phase
- Not given
- Started
- 2022-01
- Posted
- Registry
- NCT05337319
Age 18 years to Not stated (registered criteria)
Led by Beijing Anzhen HospitalBeijing
- RecruitingPrognosis and Antiplatelet Strategies for Patients With PCI and High Bleeding Risk:A Study Protocol
- Phase
- Not given
- Started
- 2022-05
- Posted
- Registry
- NCT05369442
Age not stated (registered criteria)
Led by West China HospitalChengdu
- RecruitingINSIGHTFUL-FFR Clinical Trial
- Phase
- Phase 4
- Started
- 2022-09
- Posted
- Registry
- NCT05437900
Age 18 years to 85 years (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesChengdu, Jinan, Shanghai
- RecruitingPrognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
- Phase
- Not given
- Started
- 2022-12
- Posted
- Registry
- NCT06001073
Age 3 years to 80 years (registered criteria)
Led by First Affiliated Hospital of Xi'an Jiaotong UniversityXi'an
- RecruitingEffects of Left Atrial Appendage Resection and Marshall Ligament Amputation on Clinical Outcome in Patients Undergoing Off-pump Coronary Artery Bypass
- Phase
- N/A
- Started
- 2020-04
- Posted
- Registry
- NCT04220047
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingDrug-coating Balloon Treatment in Coronary Artery Disease
- Phase
- Not given
- Started
- 2020-02
- Posted
- Registry
- NCT04255563
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- RecruitingAbbott Vascular Medical Device Registry
- Phase
- Not given
- Started
- 2020-10
- Posted
- Registry
- NCT04573660
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesNingbo, Xi'an
- RecruitingCoexistence of Cerebral and Coronary Atherosclerosis in Acute Ischemic Cerebrovascular Disease Patients Registry
- Phase
- Not given
- Started
- 2019-01
- Posted
- Registry
- NCT03788512
Age 18 years to 85 years (registered criteria)
Led by Xuanwu HospitalBeijing
- RecruitingRandomization of Single vs Multiple Arterial Grafts
- Phase
- N/A
- Started
- 2018-01
- Posted
- Registry
- NCT03217006
Age 18 years to 70 years (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Changchun, Shanghai
- RecruitingAnti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
- Phase
- Phase 4
- Started
- 2018-09
- Posted
- Registry
- NCT03378934
Age 18 years to 70 years (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingCCTA Improves Clinical Management of Stable Chest Pain
- Phase
- Not given
- Started
- 2016-01
- Posted
- Registry
- NCT04691037
Age 18 years to Not stated (registered criteria)
Led by Tianjin Chest Hospital; 2 listed hospitals as study sitesBeijing, Tianjin
- RecruitingResearch on Optimal Diagnosis and Treatment of Cardiorenal Syndrome
- Phase
- Not given
- Started
- 2016-01
- Posted
- Registry
- NCT05397392
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingCHART Study of Coronary CT Angiography in Coronary Artery Disease
- Phase
- Not given
- Started
- 2015-01
- Posted
- Registry
- NCT05380622
Age 18 years to Not stated (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- RecruitingCausation And Prognosis Analyses of Coronary Artery Diseases: A Longitudinal Cohort Study
- Phase
- Not given
- Started
- 2013-01
- Posted
- Registry
- NCT07480512
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Sun Yat-sen UniversityGuangzhou
- RecruitingRegistry of Multicenter Brain-Heart Comorbidity in China
- Phase
- Not given
- Started
- 2012-01
- Posted
- Registry
- NCT05961748
Age 18 years to Not stated (registered criteria)
Led by Beijing Tiantan Hospital; 8 listed hospitals as study sitesBeijing, Fuzhou, Harbin, Shanghai, Zhengzhou
- RecruitingRisk Factors and Outcomes in Coronary Chronic Total Occlusion
- Phase
- Not given
- Started
- 2010-01
- Posted
- Registry
- NCT06137521
Age 18 years to Not stated (registered criteria)
Led by Ruijin HospitalShanghai
- RecruitingCMR Prognostic Markers in Ischemic Heart Disease
- Phase
- Not given
- Started
- 2009-01
- Posted
- Registry
- NCT07351825
Age not stated (registered criteria)
Led by Fuwai HospitalBeijing
- RecruitingObservational Study for Left Main Disease Treatment
- Phase
- Not given
- Started
- 2007-07
- Posted
- Registry
- NCT01341327
Age 18 years to Not stated (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- Not yet recruitingIntraoperative Ultrasound Assessment of Coronary Artery and Bypass Graft Blood Flow During CABG
- Phase
- Not given
- Started
- 2027-01
- Posted
- Registry
- NCT07700524
Age 18 years to Not stated (registered criteria)
Led by Nanjing Drum Tower HospitalNanjing
- Not yet recruitingSafety and Efficacy of DCB Therapy for de Novo Lesions Under the Guidance of QFR in CHD Patients (UNIQUE-DCB-I Study )
- Phase
- N/A
- Started
- 2026-01
- Posted
- Registry
- NCT04104854
Age 18 years to 90 years (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- Not yet recruitingSafety and Efficacy of DCB Therapy for ISR Under the Guidance of QFR (UNIQUE-DCB-II Study )
- Phase
- N/A
- Started
- 2026-01
- Posted
- Registry
- NCT04119986
Age 18 years to 100 years (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- Not yet recruitingTicagrelor-Based Dual Antiplatelet Therapy Duration in CABG
- Phase
- N/A
- Started
- 2026-05
- Posted
- Registry
- NCT06981390
Age 18 years to 80 years (registered criteria)
Led by Second Hospital of Jilin UniversityChangchun
- Not yet recruitingTotal Arterial vs. Mixed Grafting in Left Coronary CABG
- Phase
- N/A
- Started
- 2026-08
- Posted
- Registry
- NCT07057713
Age 18 years to 80 years (registered criteria)
Led by Second Hospital of Jilin UniversityChangchun
- Not yet recruitingCoronary Computed Tomographic Angiography Combined With CT-FFR in Intermediate-Risk Chest Pain Patients.
- Phase
- N/A
- Started
- 2026-04
- Posted
- Registry
- NCT07140419
Age 18 years to Not stated (registered criteria)
Led by Qilu Hospital of Shandong UniversityJinan
- Not yet recruitingComparison of RA-IVL and RA-SHP in Calcified Coronary Lesions
- Phase
- N/A
- Started
- 2026-01
- Posted
- Registry
- NCT07279987
Age 18 years to Not stated (registered criteria)
Led by Beijing Chao-Yang HospitalBeijing
- Not yet recruitingDigital Remote Management for Care and Continuous Optimization Versus Usual Care in Patients With Coronary Heart Disease (DigiCare-CHD)
- Phase
- N/A
- Started
- 2026-01
- Posted
- Registry
- NCT07332494
Age 18 years to 75 years (registered criteria)
Led by Beijing Anzhen Hospital; 3 listed hospitals as study sitesBeijing, Changchun, Dalian
- Not yet recruitingPCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF
- Phase
- N/A
- Started
- 2026-12
- Posted
- Registry
- NCT07349979
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingCoronary Imaging and Metabolic Indicators-Based Risk Prediction Model for Coronary Artery Disease(CMI-RiskCAD)
- Phase
- Not given
- Started
- 2026-01
- Posted
- Registry
- NCT07353762
Age 18 years to Not stated (registered criteria)
Led by Beijing Anzhen HospitalBeijing
- Not yet recruitingSafety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk
- Phase
- N/A
- Started
- 2026-03
- Posted
- Registry
- NCT07374718
Age 18 years to Not stated (registered criteria)
Led by Shenyang Northern HospitalShenyang
- Not yet recruitingIntravascular Imaging-Guided Intravascular Lithotripsy for Severe Coronary Calcified Lesions.
- Phase
- Not given
- Started
- 2026-02
- Posted
- Registry
- NCT07444346
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingChaigui Longmu Ejiao Paste for Ischemic Heart Disease
- Phase
- Phase 2
- Started
- 2026-03
- Posted
- Registry
- NCT07478328
Age 18 years to 75 years (registered criteria)
Led by Longhua HospitalShanghai
- Not yet recruitingAngiography-Derived Physiological Indices for Outcome Prediction in Patients Undergoing OCT-Guided PCI
- Phase
- Not given
- Started
- 2026-04
- Posted
- Registry
- NCT07511231
Age 18 years to 84 years (registered criteria)
Led by Beijing Anzhen HospitalBeijing
- Not yet recruitingPredictive Role of Photon Counting Computed Tomography in Acute Coronary Syndrom Patients
- Phase
- Not given
- Started
- 2026-04
- Posted
- Registry
- NCT07536607
Age 18 years to Not stated (registered criteria)
Led by Chinese PLA General HospitalBeijing
- Not yet recruitingIntranasal Dexmedetomidine and Perioperative Myocardial Injury
- Phase
- Phase 4
- Started
- 2026-08
- Posted
- Registry
- NCT07549282
Age 18 years to 85 years (registered criteria)
Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou
- Not yet recruitingCHIP-CC Registry: A Prospective Multicenter Registry of Complex High-Risk PCI in China
- Phase
- Not given
- Started
- 2026-06
- Posted
- Registry
- NCT07557238
Age 18 years to 90 years (registered criteria)
Led by Fuwai HospitalBeijing
- Not yet recruitingLow-dose Colchicine for CABG Graft Failure Prevention
- Phase
- N/A
- Started
- 2026-09
- Posted
- Registry
- NCT07569328
Age 18 years to Not stated (registered criteria)
Led by Beijing Anzhen HospitalBeijing
- Not yet recruitingPerioperative Myocardial Injury in Patients Undergoing Coronary Artery Bypass Grafting: A Prospective Clinical Study
- Phase
- Not given
- Started
- 2026-07
- Posted
- Registry
- NCT07650487
Age 21 years to 80 years (registered criteria)
Led by Second Hospital of Jilin UniversityChangchun
- Not yet recruitingMicro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction
- Phase
- N/A
- Started
- 2026-08
- Posted
- Registry
- NCT07678021
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- Not yet recruitingEfficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
- Phase
- Phase 3
- Started
- 2026-11
- Posted
- Registry
- NCT07725484
Age 18 years to 75 years (registered criteria)
Led by Zhongshan Hospital, Fudan University; 15 listed hospitals as study sitesDalian, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Nanjing, Qingdao, Shanghai, Taiyuan, Xi'an, Zhengzhou, Zhongshan
- Not yet recruitingMedical Large Language Model-Assisted Diagnosis and Treatment in Primary Care Chronic Disease Management
- Phase
- N/A
- Started
- 2026-08
- Posted
- Registry
- NCT07740044
Age 18 years to 65 years (registered criteria)
Led by Affiliated Taizhou People's Hospital of Nanjing Medical UniversityTaizhou (Jiangsu)
- Not yet recruitingIcosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
- Phase
- Phase 4
- Started
- 2026-08
- Posted
- Registry
- NCT07762755
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- Not yet recruitingConstruction and Validation of a Coronary Artery Disease-Specific Large Language Model and Its Evaluation Framework (CorAI)
- Phase
- Not given
- Started
- 2026-08
- Posted
- Registry
- NCT07766551
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing, Hefei
- Not yet recruitingA Randomized Controlled Trial: Fuzheng Yangxin Formula for ERAS After CABG
- Phase
- N/A
- Started
- 2026-08
- Posted
- Registry
- NCT07781436
Age 20 years to 80 years (registered criteria)
Led by Peking University Third HospitalBeijing
- Not yet recruitingThe Correlation Between Sodium Urate (MSU) Deposition and Coronary Atherosclerosis in Patients With Foot Gout
- Phase
- Not given
- Started
- 2026-08
- Posted
- Registry
- NCT07784049
Age 18 years to 90 years (registered criteria)
Led by Affiliated Hospital of Qingdao UniversityQingdao
- Not yet recruitingYiqi Fumai Lyophilized Injection for Chronic Heart Failure Caused by Coronary Heart Disease
- Phase
- N/A
- Started
- 2026-09
- Posted
- Registry
- NCT07803471
Age 40 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesGuangzhou, Zhengzhou
- Not yet recruitingIntranasal Dexmedetomidine and Perioperative Myocardial Injury in Patients Having Percutaneous Coronary Interventions
- Phase
- N/A
- Started
- 2026-09
- Posted
- Registry
- NCT07847580
Age 45 years to 85 years (registered criteria)
Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou
- Not yet recruitingOPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI)
- Phase
- N/A
- Started
- 2026-09
- Posted
- Registry
- NCT07855614
Age 18 years to 80 years (registered criteria)
Led by Zhejiang Hospital; 6 listed hospitals as study sitesHangzhou
- Not yet recruitingAI-Based CT Analysis of Coronary Plaque Evolution
- Phase
- Not given
- Started
- 2026-10
- Posted
- Registry
- NCT07886996
Age 18 years to Not stated (registered criteria)
Led by Zhejiang Hospital; 3 listed hospitals as study sitesHangzhou
- Not yet recruitingRoxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery
- Phase
- Phase 4
- Started
- 2026-11
- Posted
- Registry
- NCT07912801
Age 45 years to Not stated (registered criteria)
Led by Peking University First HospitalBeijing
- Not yet recruitingPartial Cardiac Denervation for Preventing Atrial Fibrillation After CABG
- Phase
- N/A
- Started
- 2026-12
- Posted
- Registry
- NCT07918781
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 4 listed hospitals as study sitesBeijing, Changsha, Guangzhou, Nanjing
- Not yet recruitingSirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)
- Phase
- N/A
- Started
- 2026-11
- Posted
- Registry
- NCT07920055
Age 18 years to Not stated (registered criteria)
Led by Sir Run Run Shaw HospitalHangzhou
- Not yet recruitingHs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD)
- Phase
- N/A
- Started
- 2026-12
- Posted
- Registry
- NCT07920133
Age 18 years to Not stated (registered criteria)
Led by Sir Run Run Shaw HospitalHangzhou
- Not yet recruitingAIM2-NLRP3 Inflammasome Dual Inhibitor on hsCRP
- Phase
- N/A
- Started
- 2026-11
- Posted
- Registry
- NCT07933757
Age 18 years to Not stated (registered criteria)
Led by Union HospitalWuhan
- Not yet recruitingFunction-Friendly Semi-Fowler Positioning for Coronary Angiography and PCI
- Phase
- N/A
- Started
- 2026-11
- Posted
- Registry
- NCT07944716
Age 18 years to 75 years (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- Not yet recruitingProtective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery
- Phase
- N/A
- Started
- 2025-12
- Posted
- Registry
- NCT06728605
Age 18 years to 80 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingProtective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)
- Phase
- N/A
- Started
- 2025-01
- Posted
- Registry
- NCT06730802
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteBeijing, Nanjing
- Not yet recruitingDesflurane Potentially Induces Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Perioperative Procedures by Modulating Cdc42 and Clock Proteins
- Phase
- N/A
- Started
- 2025-02
- Posted
- Registry
- NCT06772558
Age 70 years to Not stated (registered criteria)
- Not yet recruitingSONICURE(SONICracker for the Treatment of UndeRExpansion)
- Phase
- N/A
- Started
- 2025-05
- Posted
- Registry
- NCT06924736
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- Not yet recruitingDCB for CAD With Type 2 Diabetes
- Phase
- N/A
- Started
- 2025-07
- Posted
- Registry
- NCT07009938
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesShanghai, Zhengzhou
- Not yet recruitingPreoperative vs Postoperative Revascularization in Coronary Heart Disease Patients Undergoing Time-Sensitive Non-Cardiac Surgery (CHRONOS-PCI)
- Phase
- N/A
- Started
- 2025-10
- Posted
- Registry
- NCT07175870
Age 18 years to 80 years (registered criteria)
Led by First Affiliated Hospital of Wenzhou Medical UniversityWenzhou
- Not yet recruitingEvaluating the Safety and Effectiveness of a Vascular Interventional Robotic System in Assisting With Percutaneous Coronary Intervention Procedures: A Prospective, Multicenter, Randomized Controlled Clinical Trial
- Phase
- N/A
- Started
- 2025-12
- Posted
- Registry
- NCT07233317
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- Not yet recruitingFor Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure, Avoiding a Return Hospital Visit for a Second Operation.
- Phase
- Not given
- Started
- 2025-12
- Posted
- Registry
- NCT07264881
Age 18 years to Not stated (registered criteria)
Led by Beijing Anzhen HospitalBeijing
- Not yet recruitingThe Correlation Between Obstructive Sleep Apnea-Related Nocturnal Hypoxemia Parameters and Coronary Microvascular Dysfunction: A Prospective Cohort Study (SLEEP-CMD)
- Phase
- Not given
- Started
- 2025-12
- Posted
- Registry
- NCT07315399
Age 18 years to 80 years (registered criteria)
Led by Beijing Anzhen HospitalBeijing
- Not yet recruitingOptimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy
- Phase
- Not given
- Started
- 2025-12
- Posted
- Registry
- NCT07354828
Age 18 years to Not stated (registered criteria)
Led by Shenyang Northern HospitalShenyang
- Not yet recruitingRemimazolam Besylate and Propofol Sedation on Hemodynamic for Coronary Artery Bypass Graft Patients
- Phase
- N/A
- Started
- 2024-07
- Posted
- Registry
- NCT06496165
Age 60 years to Not stated (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- Not yet recruitingClinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain
- Phase
- N/A
- Started
- 2023-05
- Posted
- Registry
- NCT05857904
Age 18 years to Not stated (registered criteria)
Led by Zhongshan Hospital, Fudan UniversityShanghai
- Not yet recruitingRadial Artery Versus No-touch Saphenous Vein
- Phase
- N/A
- Started
- 2023-11
- Posted
- Registry
- NCT06014047
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- Not yet recruitingColchicine Use for Primary Prevention of Coronary Artery Disease
- Phase
- Phase 3
- Started
- 2022-12
- Posted
- Registry
- NCT05175274
Age 40 years to 70 years (registered criteria)
Led by Qingdao Central HospitalQingdao
- Not yet recruitingOptimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
- Phase
- N/A
- Started
- 2021-09
- Posted
- Registry
- NCT04995159
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 67 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Chongqing, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Huai'an, Jinan, Kunming, Lanzhou, Luoyang, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Shantou, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Xi'an, Xuzhou, Yantai, Yinchuan, Zhanjiang, Zhengzhou, Zhongshan, Zhuhai, Zibo
- Enrolling by invitationA Coronary Computed Tomography Angiography-guided Intervention for High Risk Cardiovascular Disease Population in Rural China
- Phase
- N/A
- Started
- 2026-04
- Posted
- Registry
- NCT07416344
Age 40 years to 75 years (registered criteria)
Led by Second Affiliated Hospital of Harbin Medical UniversityHarbin
- Enrolling by invitationCoronary Arterial Microcirculation and Metabolism
- Phase
- Not given
- Started
- 2025-02
- Posted
- Registry
- NCT07074847
Age 18 years to 80 years (registered criteria)
Led by Shaanxi Provincial People's HospitalXi'an
- Enrolling by invitationInfluencing Factors and Outcomes of DCB Angioplasty
- Phase
- Not given
- Started
- 2024-10
- Posted
- Registry
- NCT06620458
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteZhengzhou
- Enrolling by invitationHealth Behavior Management Program for Patients With Coronary Heart Disease
- Phase
- N/A
- Started
- 2024-10
- Posted
- Registry
- NCT07330882
Age 18 years to 80 years (registered criteria)
Led by First Affiliated Hospital of Bengbu Medical UniversityBengbu
- Enrolling by invitationIdentifying Vulnerable CoronAry PLaqUes With Artificial IntElligence-assisted CT Angiography
- Phase
- Not given
- Started
- 2023-07
- Posted
- Registry
- NCT06025305
Age 18 years to Not stated (registered criteria)
Led by Jinling HospitalNanjing
- Enrolling by invitationEvaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease
- Phase
- Not given
- Started
- 2016-04
- Posted
- Registry
- NCT02751060
Age 18 years to Not stated (registered criteria)
Led by Tongji HospitalWuhan
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Before contacting a hospital
The same for every disease, so it is kept on one page. Each hospital page also has an enquiry letter in English and Chinese, and a name card to show staff.
- How to startTalk with the treating doctor, prepare the records hospitals ask for, then write to two or three hospitals.
- Questions to check before asking about a trialWhat the registered criteria usually ask about, and what to ask the study team.
- Common questionsInternational patients, costs, trials and visas.
Where these numbers come from
Papers
5,119 English-language PubMed papers on coronary heart disease with an author in mainland China, 2021–2025; a hospital led a paper when its first or last author lists it first. Run the PubMed search
Trials
ClinicalTrials.gov records with a listed hospital as lead sponsor or site, as of 18 Nov 2026. ChiCTR is not included. Search ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.